Double blind controlled study of treatment of atopic eczema with a preparation of hydrocortisone in a new drug delivery system versus betamethasone 17-valerate

A double blind study has shown that topical treatment with a new preparation of I% hydrocortisone in a stabilized carbamide drug delivery system effectively controls atopic eczema without the hazards of potent fluorinated corticosteroids. Clinical evaluation confirms that it is at least as effective as 0·1% betamethasone 17‐valerate. The preparation has the physical properties of both a cream and an ointment and can be used in place of either. It has a high level of patient acceptance and can be used in fissured eczemas without causing any sensations of stinging or smarting.